Cell-free Synthesis of Transfection-grade Plasmid DNA for Automated Processing

Vanderbilt University

Daiichi Sankyo is seeking cell-free plasmid DNA synthesis technology for automated pharmaceutical processing.

Reference No.

RFP-2025-3128

Description

Daiichi Sankyo, a global pharmaceutical company focused on creating innovative pharmaceuticals, is seeking a fully cell-free, in vitro technology capable of synthesizing and amplifying plasmid DNA without relying on E. coli.

This Request for Proposal (RFP) is issued by Kansas City Board of Public Utilities ('Purchaser') for a Workforce Management Software solution. The scope includes absence management, scheduling, time & labor, and related automations to improve productivity, redual review, and support effective allocation of resources. Modules should support configurable rules, role-based permissions, and audit-ready reporting. This Request for Proposal (RFP) is issued by Kansas City Board of Public Utilities ('Purchaser') for a Workforce Management Software solution. The scope includes absence management, scheduling, time & labor, and related automations to improve productivity, reduce manual review, and support effective allocation of resources. Modules should support configurable rules, role-based permissions, and

Unlock full RFP details

Key Requirements

RFP Submission Requirements for Vanderbilt Cell-free Plasmid DNA

Contact Information

Get contact info

What you’ll get when you unlock

All the details after a short form. No spam